Quercetin and low-dose gamma irradiation modulate oxidative stress, inflammation, autophagy, and apoptosis in DEN-induced hepatocarcinogenesis
Résumé
BACKGROUND: Diethylnitrosamine (DEN) induces hepatic injury and can promote hepatocarcinogenesis. Quercetin (QR) and low-dose gamma irradiation (LDR) have been explored as hepatoprotective and anticancer-modulating agents, but their combined effects in DEN-induced liver cancer have not been previously examined. AIM: To, for the first time, evaluate the novel combination of QR with LDR and compare its efficacy to QR or LDR alone in modulating DEN-induced liver cancer. METHODS: Hepatic injury was induced in ninety male rats by intraperitoneal DEN administration (75 mg/kg weekly for 3 weeks, then 100 mg/kg weekly for 3 weeks). After 6 weeks, hepatic injury establishment was confirmed histopathologically in a subset of rats. Animals were then randomized into five groups for an 8-week treatment period: (C) normal control; (DEN) no further treatment; (DEN + QR) quercetin (50 mg/kg/day, oral); (DEN + IR) fractionated low-dose γ-irradiation (0.25 Gy once weekly for 4 weeks, total 1 Gy); (DEN + QR+IR) combined QR + IR. The total experimental duration was 14 weeks. RESULTS: DEN induced severe hepatotoxicity, with significantly elevated serum ALT and AST compared to controls (p < 0.001). Markers of oxidative stress were markedly increased, while antioxidant enzymes and GSH were significantly reduced (p < 0.001). DEN also led to substantial activation of inflammatory and growth signaling pathways, including NF-κB, STAT-3, mTOR, and p38 MAPK (p < 0.001). Autophagy markers ULK-1, LC3-II, and ATG5 were significantly suppressed, and a pro-survival shift was evident with reduced caspase-3 activity and increased BCL-2 expression (p < 0.001).Treatment with quercetin (DEN + QR) or low-dose γ-irradiation (DEN + IR) alone significantly mitigated these alterations versus DEN, restoring liver enzymes, reducing oxidative stress and inflammation, and promoting apoptotic signaling (p < 0.001). The combination therapy (DEN + QR+IR) produced the most pronounced effects, with greater normalization of all biochemical and molecular parameters compared to DEN and to either monotherapy (p < 0.001). These changes were statistically superior to those observed with quercetin or irradiation alone (p < 0.01). Flow cytometry confirmed enhanced apoptosis and altered cell cycle dynamics in the combination group. Histopathological analysis showed markedly improved hepatic architecture and the lowest pathology scores with combination therapy (p < 0.001 vs. DEN). CONCLUSION: This study reveals, for the first time, a combined hepatoprotective effect of quercetin with low-dose gamma irradiation in DEN-induced liver pathology, suggesting new mechanistic insights and promising translational potential for combined therapy in DEN-associated liver injury and hepatocarcinogenesis. CLINICAL TRIAL: This work isn't a clinical Trial.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 01/10/2026. Le document reste hébergé par sa source.
Voir le document à la source →